Karl-Heinz Klingler

Title: Karl-Heinz Klingler: Innovator in Pharmaceutical Compounds

Introduction

Karl-Heinz Klingler is a notable inventor based in Langen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic effects. With a total of 2 patents, his work has implications for treating various medical conditions.

Latest Patents

Klingler's latest patents include innovative compounds such as 4,5-dihydro-4-oxo-pyrrolo[1,2-a]quinoxalinones. These compounds are characterized by a complex formula where the phenyl ring can contain a nitrogen atom instead of a CH group. The compounds exhibit anti-allergic, anti-asthmatic, anxiolytic, and hypotensive effects, showcasing their potential in therapeutic applications. Additionally, he has developed basic substituted alkyl theophylline derivatives, produced through catalytic hydrogenation, which further emphasizes his expertise in pharmaceutical chemistry.

Career Highlights

Throughout his career, Klingler has worked with reputable companies such as Asta Medica and Deutsche Gold- und Silber-Scheideanstalt Vormals Roessler. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in the pharmaceutical industry.

Collaborations

Klingler has collaborated with esteemed colleagues, including Hans-Reinhold Dieter and Jurgen Engel. These partnerships have likely enriched his research and development efforts, leading to innovative solutions in the field.

Conclusion

Karl-Heinz Klingler's contributions to pharmaceutical innovations highlight his role as a significant inventor in the industry. His patents and collaborations reflect a commitment to advancing medical science through innovative compounds.